Policy Research Assistant Jobs in Indiana (NOW HIRING)

IBRI is poised to transform life sciences—and for millions of people, even life itself.

The Opportunity:

The IBRI is seeking motivated undergraduate or graduate students for our Summer Internship Program. Interns will gain hands-on experience in a dynamic research environment, working alongside scientists and professionals on active projects that contribute to real-world scientific advancement.

Program Dates: May 17, 2027 – August 6, 2027

Application Deadline: Applications will be accepted through November 30, 2026. For priority consideration, apply by October 15, 2026.

Schedule: 35 hours per week

Stipend: This internship includes a stipend of $9,650 for the full program, disbursed in bi-weekly installments on or before the 7th and 22nd of each month

Responsibilities:

• Assist with lab experiments, sample preparation, and data collection.
• Review scientific literature and summarize key findings.
• Record results clearly using lab notebooks and digital tools.
• Help analyze data and prepare charts, figures, or short summaries.
• Join team meetings, trainings, and scientific discussions.
• Follow lab safety, biosafety, and ethical research practices.

Qualifications:

• Enrolled in (or recently graduated from) an Indiana university undergraduate and/or graduate program OR having graduated from an Indiana High School.
• Degree in a field related to biology and/or chemistry.
• Strong interest in scientific research.
• Excellent organizational and communication skills.
• Ability to work independently and collaboratively in a team setting.
• Interested in pursuing graduate studies or a career in research or science policy.
• Commitment to the full duration of the internship.
• Familiarity with software such as Excel, R, Python, or statistical tools (preferred).
• Basic understanding of laboratory techniques and data analysis tools (preferred). 

About Us:

The Indiana Biosciences Research Institute (IBRI) is a first-in-class translational medicine institute dedicated to advancing life sciences in the race to eliminate disease and improve human health and life.

By connecting early-stage biotech companies with cutting-edge life science discoveries —and backed by the mission and resources of industry leaders, investors, and philanthropic partners—IBRI is successfully evolving a new, independent model to conquer disease, uniting previously fragmented forces in the quest for cures.

Carefully curating and supporting early-stage companies with investment, talent, and space, IBRI strategically accelerates drug discovery. Our work benefits from the relatively low cost of living and doing business here, allowing more resources to be directed toward science.

Fueled by the same entrepreneurial creativity as the groundbreaking scientific work we support, IBRI’s labs advance research across the frontiers of diabetes, metabolic disease, Alzheimer’s disease, and rare pediatric diseases. Our ambitious public–private vision cultivates talent while efficiently bridging the gap between research-driven inquiry and profit-driven drug development.

At IBRI, cures are launched on a clear pathway to clinical trials, enabled by the combined resources and experience of our academic and industry partners, without the typical pressure to deliver rapid results for commercialization. IBRI labs pursue breakthroughs that might never happen elsewhere. Breakthroughs are happening here. Our novel financing model ensures that when discoveries are ready for clinical trials, the intellectual property is sold back to industry or spun off, creating a direct stream of revenue.

By every measure, the IBRI model demonstrates a novel approach that delivers rewards. Scientific bench work is nurtured, drug discovery is advanced, workforce development is continuous, investors see returns, and donors see impact. Most importantly, IBRI’s structure and portfolio of accomplishments matter to the patients whose lives are improved—or even saved—by this forward-looking approach to life sciences.

IBRI is driven to bring next-generation therapies to market with an understanding of the complex pressures that often bind innovation to economics. After more than a decade, the evidence is clear: IBRI is poised to transform life sciences—and for millions of people, even life itself.

Equal Employment Opportunity:

The IBRI provides equal employment opportunities to all employees and applicants and does not discriminate based on age, race, color, religion, gender, sexual orientation, gender identity, gender expression, national origin, protected veteran status, disability, or any other legally protected status.